R
Rezolute, Inc. (RZLT)
NCM – Real vaqt narxi. Valyuta: USD
3.30
+0.13 (4.10%)
Yopilishda: May 12, 2026, 4:00 PM EDT
3.41
+0.11 (3.26%)
Bozor oldidan: May 13, 2026, 5:56 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.30
+0.13 (4.10%)
Yopilishda: May 12, 2026, 4:00 PM EDT
3.41
+0.11 (3.26%)
Bozor oldidan: May 13, 2026, 5:56 AM EDT
Rezolute, Inc., kechki bosqichdagi kamyob kasalliklar kompaniyasi, Qo'shma Shtatlarda giperinsulinizmdan kelib chiqqan gipoglikemiyasi bo'lgan shaxslar uchun natijalarni yaxshilashga qaratilgan. Uning yetakchi klinik aktivlari - bu gipoglikemiya, ultra-kam uchraydigan bolalar genetik kasalligi bo'lgan tug'ma giperinsulinizm davolash uchun 3-bosqich klinik sinovda bo'lgan, shuningdek, gipoglikemiya davolash uchun tomir ichiga yuboriladigan inson monoklonal antikori ersodetug; va ersodetugning giperinsulinizm shishini davolash uchun klinik sinovlari. Kompaniya ilgari AntriaBio, Inc. nomi bilan tanilgan va 2017 yil dekabr oyida Rezolute, Inc. nomini o'zgartirgan. Rezolute, Inc. 2010 yilda tashkil etilgan va Redwood City, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Brian Kenneth Roberts M.D. | Chief Medical Officer |
| Dr. Davelyn Eaves Hood M.B.A., M.D. | Director and Head of Scientific & Patient Affairs |
| Dr. Raj Agrawal M.D. | VP & Head of Ophthalmological Clinical Development |
| Mr. Chris Milks | VP & Head of Finance |
| Mr. Daron G. Evans M.B.A., M.S. | Chief Financial & Business Officer |
| Mr. Michael Covarrubias | Senior VP & Head of Program & Portfolio Management |
| Mr. Michael R. Deperro | Senior VP & Head of Operations |
| Mr. Nevan Charles Elam J.D. | Founder, CEO, Principal Financial Officer & Acting Chairman of the Board |
| Ms. Melissa Quinn | Senior Director of People and Culture |
| Ms. Robyn Sweinhart | VP & Head of Quality |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-04 | 8-K | tm2613408d1_8k.htm |
| 2026-03-24 | 8-K | tm269642d1_8k.htm |
| 2026-02-12 | 10-Q | rzlt-20251231x10q.htm |
| 2026-01-07 | 8-K | tm262357d1_8k.htm |
| 2025-12-05 | S-3ASR | tm2532714-1_s3asr.htm |
| 2025-11-21 | 8-K | tm2531775d2_8k.htm |
| 2025-11-12 | 8-K | tm2530840d1_8k.htm |
| 2025-11-06 | 8-K | tm2529989d1_8k.htm |
| 2025-10-21 | 8-K | tm2529201d1_8k.htm |
| 2025-10-07 | DEF 14A | rzlt-20251119xdef14a.htm |